Market Cap 4.42B
Revenue (ttm) 0.00
Net Income (ttm) -183.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.15
Volume 1,487,000
Avg Vol 3,126,846
Day's Range N/A - N/A
Shares Out 99.70M
Stochastic %K 30%
Beta 2.20
Analysts Strong Sell
Price Target $57.80

Company Profile

Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder. The company was formerly known as Mind Me...

Industry: Biotechnology
Sector: Healthcare
Phone: 212 220 6633
Address:
One World Trade Center, Suite 8500, New York, United States
Jackie_O_II
Jackie_O_II Jul. 20 at 2:53 AM
$DFTX $ATAI $CMPS I own all 3. They were and are my picks for the space. One has a buyout. The other two remain to be seen. This space is HOT 🔥🔥 🔥
0 · Reply
RuddyRolls
RuddyRolls Jul. 20 at 2:39 AM
@laidbacklu $DFTX $CMPS COMP360 (TRD) will be deployed off-label no doubt - as only approved in first few years. $HELP has a candidate for Generalized Anxiety Disorder (GAD): HLP004. "A proprietary deuterated formulation of $N,N$-dimethyltryptamine (DMT) administered via intramuscular injection, paired with psychotherapy. Clinical Findings: Topline Phase 2 data revealed clinically meaningful reductions in anxiety, with durable remission rates extending up to six months following treatment, and no drug-related serious adverse events reported. Patent Protection: Helus Pharma holds robust intellectual property and patent coverage for this deuterated DMT program." https://finance.yahoo.com/news/cybin-help-down-27-3-131141505.html
1 · Reply
twiggs462
twiggs462 Jul. 20 at 2:03 AM
$DFTX $CMPS CNBC - The market for psychedelic drugs to treat mental health conditions gets a big buy signal https://www.cnbc.com/2026/07/19/psychedelic-drugs-mental-health.html
1 · Reply
Juuanrod
Juuanrod Jul. 19 at 11:28 PM
$DFTX boys when are we dropping the news
1 · Reply
RuddyRolls
RuddyRolls Jul. 19 at 11:07 PM
$CMPS $DFTX $HELP Strong point. But doesn't explain why CMPS is 4x HELP mkt cap (2x might be about right - efficacy aside, relative just to time to outcome) and DFTX is 3.5 almost 4x CMPS mkt cap. Perhaps then it appears that DFTX is appropriately priced given probable TAM in a multi-player market - and both CMPS and HELP are due to triple. Or perhaps DFTX is due to double again and the others 6x. Lets see.
4 · Reply
MichaelNaussCMT
MichaelNaussCMT Jul. 19 at 8:47 PM
$DFTX I have no idea but remember it’s not an “all or none” game. If your ever worried about being too big in the position then sell some. For me. I’m waiting for the GAD results. If we pop to 60 I’ll sell half for like a 10X gain and hold the rest until a buyout or retirement level.
0 · Reply
Millionaire11
Millionaire11 Jul. 19 at 8:15 PM
0 · Reply
twiggs462
twiggs462 Jul. 19 at 6:47 PM
$DFTX $CMPS CNBC - The market for psychedelic drugs to treat mental health conditions gets a big buy signal https://www.cnbc.com/2026/07/19/psychedelic-drugs-mental-health.html
1 · Reply
ngalifi1
ngalifi1 Jul. 19 at 4:54 PM
$DFTX @MichaelNaussCMT talking to my neighbour, and he says I should be taking some profit now. but i feel this has room to run to 50 60 dollars on next results. My avg is around 5, 6 dollars do you think im being silly by not selling? i feel there is still alot more value to be unlocked woth GAD trial. your insight would be appreciated here!
1 · Reply
Millionaire11
Millionaire11 Jul. 18 at 11:30 PM
1 · Reply
Latest News on DFTX
Biotech ETF Index Surges 10% After Rebalance

Jun 25, 2026, 11:31 AM EDT - 24 days ago

Biotech ETF Index Surges 10% After Rebalance

ALKS APGE DYN KLRA KYMR MANE MIRM


Definium Therapeutics rises 21.8%

2026-06-24T16:05:36.000Z - 25 days ago

Definium Therapeutics rises 21.8%


Definium Therapeutics rises 17.7%

2026-06-24T14:05:51.000Z - 25 days ago

Definium Therapeutics rises 17.7%


Definium Therapeutics 20.6M share Secondary priced at $34.00

2026-06-24T10:20:19.000Z - 25 days ago

Definium Therapeutics 20.6M share Secondary priced at $34.00


Definium Therapeutics offers to sell $500M in common stock

2026-06-22T20:18:37.000Z - 27 days ago

Definium Therapeutics offers to sell $500M in common stock


Definium Therapeutics, Inc. Announces Proposed Public Offering

Jun 22, 2026, 4:01 PM EDT - 27 days ago

Definium Therapeutics, Inc. Announces Proposed Public Offering


Definium Therapeutics Transcript: Study result

Jun 22, 2026, 8:00 AM EDT - 27 days ago

Definium Therapeutics Transcript: Study result


Definium Therapeutics Press release: Study result

Jun 22, 2026, 8:00 AM EDT - 27 days ago

Definium Therapeutics Press release: Study result


Definium Therapeutics Slides: Study result

Jun 22, 2026, 8:00 AM EDT - 27 days ago

Definium Therapeutics Slides: Study result


Definium Therapeutics Slides: Corporate presentation

Jun 22, 2026, 7:00 AM EDT - 27 days ago

Definium Therapeutics Slides: Corporate presentation


Definium Therapeutics Transcript: AGM 2026

Jun 11, 2026, 10:00 AM EDT - 5 weeks ago

Definium Therapeutics Transcript: AGM 2026


Definium Therapeutics Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Definium Therapeutics Earnings Call Transcript: Q1 2026


Definium Therapeutics Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Definium Therapeutics Earnings release: Q1 2026


Definium Therapeutics Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Definium Therapeutics Quarterly report: Q1 2026


Definium Therapeutics Slides: Corporate presentation

May 7, 2026, 4:00 PM EDT - 2 months ago

Definium Therapeutics Slides: Corporate presentation


Definium Therapeutics Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Definium Therapeutics Proxy statement: Proxy filing


Definium Therapeutics Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Definium Therapeutics Proxy statement: Proxy filing


Definium Therapeutics Transcript: Investor Day 2026

Apr 22, 2026, 10:00 AM EDT - 3 months ago

Definium Therapeutics Transcript: Investor Day 2026


Definium Therapeutics Slides: FY 2026

Apr 22, 2026, 10:00 AM EDT - 3 months ago

Definium Therapeutics Slides: FY 2026


Psychedelic stocks rally with Trump's support

Apr 20, 2026, 8:26 AM EDT - 3 months ago

Psychedelic stocks rally with Trump's support

ATAI CMPS GHRS


Definium Therapeutics Transcript: Stifel 2026 Virtual CNS Forum

Mar 17, 2026, 3:30 PM EDT - 4 months ago

Definium Therapeutics Transcript: Stifel 2026 Virtual CNS Forum


Definium Therapeutics Earnings Call Transcript: Q4 2025

Feb 26, 2026, 4:30 PM EST - 5 months ago

Definium Therapeutics Earnings Call Transcript: Q4 2025


Definium Therapeutics Annual report: Q4 2025

Feb 26, 2026, 4:30 PM EST - 5 months ago

Definium Therapeutics Annual report: Q4 2025


Definium Therapeutics Earnings release: Q4 2025

Feb 26, 2026, 4:30 PM EST - 5 months ago

Definium Therapeutics Earnings release: Q4 2025


Definium Therapeutics Slides: Corporate presentation

Feb 26, 2026, 4:00 PM EST - 5 months ago

Definium Therapeutics Slides: Corporate presentation


Definium Therapeutics Slides: Corporate presentation

Jan 12, 2026, 2:45 PM EST - 6 months ago

Definium Therapeutics Slides: Corporate presentation


MindMed Announces New Employee Inducement Grant

Dec 15, 2025, 4:01 PM EST - 7 months ago

MindMed Announces New Employee Inducement Grant


MindMed Announces New Employee Inducement Grants

Dec 1, 2025, 4:01 PM EST - 8 months ago

MindMed Announces New Employee Inducement Grants


Definium Therapeutics Slides: Corporate Presentation

Nov 9, 2025, 6:00 PM EST - 9 months ago

Definium Therapeutics Slides: Corporate Presentation


Definium Therapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

Definium Therapeutics Earnings Call Transcript: Q3 2025


Definium Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

Definium Therapeutics Quarterly report: Q3 2025


Definium Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

Definium Therapeutics Earnings release: Q3 2025


MindMed Reports Q3 2025 Financial Results and Business Updates

Nov 6, 2025, 4:01 PM EST - 9 months ago

MindMed Reports Q3 2025 Financial Results and Business Updates


Definium Therapeutics Slides: Corporate Presentation

Nov 6, 2025, 7:00 AM EST - 9 months ago

Definium Therapeutics Slides: Corporate Presentation


MindMed to Participate in Upcoming Investor Conferences

Nov 5, 2025, 7:01 AM EST - 9 months ago

MindMed to Participate in Upcoming Investor Conferences


MindMed to Report Q3 2025 Financial Results on November 6, 2025

Oct 30, 2025, 4:01 PM EDT - 9 months ago

MindMed to Report Q3 2025 Financial Results on November 6, 2025


Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

Oct 29, 2025, 4:01 PM EDT - 9 months ago

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering


MindMed to Participate in September Investor Conferences

Aug 28, 2025, 7:00 AM EDT - 11 months ago

MindMed to Participate in September Investor Conferences


Definium Therapeutics Earnings Call Transcript: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 1 year ago

Definium Therapeutics Earnings Call Transcript: Q2 2025


Definium Therapeutics Quarterly report: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 1 year ago

Definium Therapeutics Quarterly report: Q2 2025


Definium Therapeutics Earnings release: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 1 year ago

Definium Therapeutics Earnings release: Q2 2025


Definium Therapeutics Slides: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 1 year ago

Definium Therapeutics Slides: Q2 2025


Definium Therapeutics Transcript: AGM 2025

Jun 12, 2025, 10:00 AM EDT - 1 year ago

Definium Therapeutics Transcript: AGM 2025


MindMed to Participate in June Investor Conferences

May 28, 2025, 7:00 AM EDT - 1 year ago

MindMed to Participate in June Investor Conferences


Definium Therapeutics Earnings Call Transcript: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Definium Therapeutics Earnings Call Transcript: Q1 2025


Definium Therapeutics Quarterly report: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Definium Therapeutics Quarterly report: Q1 2025


Definium Therapeutics Earnings release: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Definium Therapeutics Earnings release: Q1 2025


Definium Therapeutics Slides: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Definium Therapeutics Slides: Q1 2025


Jackie_O_II
Jackie_O_II Jul. 20 at 2:53 AM
$DFTX $ATAI $CMPS I own all 3. They were and are my picks for the space. One has a buyout. The other two remain to be seen. This space is HOT 🔥🔥 🔥
0 · Reply
RuddyRolls
RuddyRolls Jul. 20 at 2:39 AM
@laidbacklu $DFTX $CMPS COMP360 (TRD) will be deployed off-label no doubt - as only approved in first few years. $HELP has a candidate for Generalized Anxiety Disorder (GAD): HLP004. "A proprietary deuterated formulation of $N,N$-dimethyltryptamine (DMT) administered via intramuscular injection, paired with psychotherapy. Clinical Findings: Topline Phase 2 data revealed clinically meaningful reductions in anxiety, with durable remission rates extending up to six months following treatment, and no drug-related serious adverse events reported. Patent Protection: Helus Pharma holds robust intellectual property and patent coverage for this deuterated DMT program." https://finance.yahoo.com/news/cybin-help-down-27-3-131141505.html
1 · Reply
twiggs462
twiggs462 Jul. 20 at 2:03 AM
$DFTX $CMPS CNBC - The market for psychedelic drugs to treat mental health conditions gets a big buy signal https://www.cnbc.com/2026/07/19/psychedelic-drugs-mental-health.html
1 · Reply
Juuanrod
Juuanrod Jul. 19 at 11:28 PM
$DFTX boys when are we dropping the news
1 · Reply
RuddyRolls
RuddyRolls Jul. 19 at 11:07 PM
$CMPS $DFTX $HELP Strong point. But doesn't explain why CMPS is 4x HELP mkt cap (2x might be about right - efficacy aside, relative just to time to outcome) and DFTX is 3.5 almost 4x CMPS mkt cap. Perhaps then it appears that DFTX is appropriately priced given probable TAM in a multi-player market - and both CMPS and HELP are due to triple. Or perhaps DFTX is due to double again and the others 6x. Lets see.
4 · Reply
MichaelNaussCMT
MichaelNaussCMT Jul. 19 at 8:47 PM
$DFTX I have no idea but remember it’s not an “all or none” game. If your ever worried about being too big in the position then sell some. For me. I’m waiting for the GAD results. If we pop to 60 I’ll sell half for like a 10X gain and hold the rest until a buyout or retirement level.
0 · Reply
Millionaire11
Millionaire11 Jul. 19 at 8:15 PM
0 · Reply
twiggs462
twiggs462 Jul. 19 at 6:47 PM
$DFTX $CMPS CNBC - The market for psychedelic drugs to treat mental health conditions gets a big buy signal https://www.cnbc.com/2026/07/19/psychedelic-drugs-mental-health.html
1 · Reply
ngalifi1
ngalifi1 Jul. 19 at 4:54 PM
$DFTX @MichaelNaussCMT talking to my neighbour, and he says I should be taking some profit now. but i feel this has room to run to 50 60 dollars on next results. My avg is around 5, 6 dollars do you think im being silly by not selling? i feel there is still alot more value to be unlocked woth GAD trial. your insight would be appreciated here!
1 · Reply
Millionaire11
Millionaire11 Jul. 18 at 11:30 PM
1 · Reply
VikaDelic
VikaDelic Jul. 18 at 5:48 PM
$DFTX tell me you already spent that tiny ATAI payout, without telling me 🤣 get ready to see how it’s done my sad bro…
1 · Reply
twiggs462
twiggs462 Jul. 18 at 2:54 PM
I personally think $ATAI sold becuase they know that cannot compete with $DFTX or $CMPS short term. Those two are going to take the spotlight and investors and $ATAI would have run out of money. I bet $LLY will take BPL-003 to market, but $ATAI would have not been able to
2 · Reply
twiggs462
twiggs462 Jul. 18 at 2:42 PM
$DFTX will be the darling in the space. it will soon be front page news.
1 · Reply
leLu83
leLu83 Jul. 18 at 1:09 AM
$DFTX investors from 2021 still in the Red 😂
2 · Reply
UncleJudd
UncleJudd Jul. 17 at 7:05 PM
$DFTX $CMPS Worth reading. https://www.psychologytoday.com/ca/blog/addiction-outlook/202607/how-can-a-drug-lasting-hours-change-the-brain-for-months
0 · Reply
WhizBuckley
WhizBuckley Jul. 17 at 5:14 PM
$ATAI word salad for "I needed the money" https://christianangermayer.substack.com/p/my-love-letter-to-psychedelics-and $DFTX $CMPS $HELP $GHRS
4 · Reply
ngalifi1
ngalifi1 Jul. 17 at 4:59 PM
$DFTX FAKE NEWS
1 · Reply
Musty1129
Musty1129 Jul. 17 at 1:48 PM
$DFTX 🔥🔥🔥🔥🔥🔥
4 · Reply
twiggs462
twiggs462 Jul. 17 at 12:24 PM
The Lilly–AtaiBeckley transaction materially increases the probability that major pharmaceutical companies will evaluate Compass and Definium as strategic opportunities. $DFTX $CMPS
1 · Reply
WhizBuckley
WhizBuckley Jul. 17 at 10:49 AM
After digging deeper into $ATAI $LLY deal looks like someone needed to cover his massive crypto losses and screwed shareholders. Awful deal that impacts rest of sector $CMPS $DFTX $HELP should go public on their own and compete with big pharma
0 · Reply
Roaring_Capybara
Roaring_Capybara Jul. 17 at 1:51 AM
$DFTX Small, early stages, but HUGE potential psychedelic --- for treatment of multiple applications such as pain, depression, and anxiety = MIRA. They have Ketamir-2 in their pipeline which provides similar relief as ketamine, but unlike ketamine and its other derivatives ......... it is NOT classified as a controlled substance. This will make prescribing and treatment with Ketamir-2 far more easier for doctors and far less restrictive for patients.
0 · Reply
TurboFrogz
TurboFrogz Jul. 16 at 11:52 PM
This $ATAI deal is now dragging the rest of the sector down and might continue doing so until new catalysts from the legit companies arrive. Especially $DFTX & $CMPS. It’s completely valid and understandable. Has retail overvalued medical psychedelics? Was this actually a good deal selling during some hype? Are the other companies lying to us as well? I’d like to think $DFTX & $CMPS are different and have so far shown that they actually trying to build something. Now in hindsight, the $ATAI CEO never really tried growing the company in a healthy way in comparison. Sellout seems to have always been the plan here.
4 · Reply